Improving care in ovarian cancer: the role of a clinico-pathological meeting.

Simple item page
dc.contributor.authorGanesan, Prasanthen_US
dc.contributor.authorKumar, Laliten_US
dc.contributor.authorHariprasad, Roopaen_US
dc.contributor.authorGupta, Aartien_US
dc.contributor.authorDawar, Ren_US
dc.contributor.authorVijayaraghavan, Men_US
dc.date.accessioned2008-09-27en_US
dc.date.accessioned2009-06-03T06:54:50Z
dc.date.available2008-09-27en_US
dc.date.available2009-06-03T06:54:50Z
dc.date.issued2008-09-27en_US
dc.description.abstractBACKGROUND: We assessed the impact of clinico-pathological meetings on the diagnosis and management of patients with ovarian cancer. METHODS: Between January 2005 and December 2006, about 400 patients of suspected or confirmed ovarian cancer were evaluated in the 'Gynaecology Tumour Clinic'. Of these, 108 cases were referred for discussion in the weekly clinico-pathology meeting for various indications. These cases were retrospectively analysed regarding their initial clinical and pathological diagnosis, the indication for referring the case for discussion in the meeting and the impact this had on the overall management. Alterations in diagnosis, which impacted management, were classified as 'major changes' and those, which did not, were called 'minor changes'. RESULTS: Ninety-one of the 108 cases discussed were available for analysis; 75.8% of cases were initially diagnosed as epithelial ovarian cancers. In 48 of 91 cases (52%), there was an alteration in the diagnosis as a direct result of discussion in the meeting, mainly after clarifications regarding histological grading in 34 cases. Of the remaining 14 cases, 3 had a change in histopathological diagnosis; 2 cases, which were initially labelled as undifferentiated tumours, had their diagnosis clarified; and in the remaining 9 cases, in which the primary site was not known, a possible primary site could be assigned (with the help of clinical, radiological and pathological inputs). Among the 14 cases with alterations other than grading, the change was contributed by slide review alone in 7 cases and in the rest by a combination of slide review and clinical inputs. As a direct outcome of the meeting, 20 of 91 cases (22%) had their management plan modified (major change). CONCLUSION: The practice of conducting weekly clinicopathological meetings has a major impact on the management of cases of ovarian cancer.en_US
dc.description.affiliationDr B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India.en_US
dc.identifier.citationGanesan P, Kumar L, Hariprasad R, Gupta A, Dawar R, Vijayaraghavan M. Improving care in ovarian cancer: the role of a clinico-pathological meeting. National Medical Journal of India. 2008 Sep-Oct; 21(5): 225-7en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/119362
dc.language.isoengen_US
dc.source.urihttps://www.nmji.inen_US
dc.subject.meshFemale
dc.subject.meshGroup Processes
dc.subject.meshHumans
dc.subject.meshIndia
dc.subject.meshOvarian Neoplasms --diagnosis
dc.subject.meshOvarian Neoplasms --drug therapy
dc.subject.meshOvarian Neoplasms --pathology
dc.subject.meshOvarian Neoplasms --surgery
dc.subject.meshPatient Care Team --statistics & numerical data
dc.subject.meshReferral and Consultation --statistics & numerical data
dc.subject.meshRetrospective Studies
dc.titleImproving care in ovarian cancer: the role of a clinico-pathological meeting.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
National Medical Journal of India